Erratum: Increased fatty acid synthase expression in prostate biopsy cores predicts higher Gleason score in radical prostatectomy specimen
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6890
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Erratum: Increased fatty acid synthase expression in prostate biopsy cores predicts higher Gleason score in radical prostatectomy specimen ; volume:15 ; number:1 ; day:13 ; month:5 ; year:2015 ; pages:1 ; date:12.2015
BMC clinical pathology ; 15, Heft 1 (13.5.2015), 1, 12.2015
- Urheber
-
Hamada, Shinsuke
- Beteiligte Personen und Organisationen
-
Horiguchi, Akio
Kuroda, Kenji
Ito, Keiichi
Asano, Tomohiko
Miyai, Kosuke
Iwaya, Keiichi
SpringerLink (Online service)
- DOI
-
10.1186/s12907-015-0007-3
- URN
-
urn:nbn:de:1111-2016110317140
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hamada, Shinsuke
- Horiguchi, Akio
- Kuroda, Kenji
- Ito, Keiichi
- Asano, Tomohiko
- Miyai, Kosuke
- Iwaya, Keiichi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Increased fatty acid synthase expression in prostate biopsy cores predicts higher Gleason score in radical prostatectomy specimen
Correlation of MRI-lesion targeted biopsy vs. systematic biopsy gleason score with final pathologicalg gleason score after radical prostatectomy
Machine learning prediction of Gleason grade group upgrade between in-bore biopsy and radical prostatectomy pathology
MRI-fusion targeted vs. systematic prostate biopsy - how does the biopsy technique affect Gleason grade concordance and upgrading after radical prostatectomy?
Mri-fusion targeted vs. Systematic prostate biopsy–how does the biopsy technique affect gleason grade concordance and upgrading after radical prostatectomy?
Predicting Gleason sum upgrading from biopsy to radical prostatectomy pathology: a new nomogram and its internal validation
Preoperative prostate health index predicts adverse pathology and Gleason score upgrading after radical prostatectomy for prostate cancer
Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy
Influence of biopsy gleason score on the risk of lymph node invasion in patients with intermediate-risk prostate cancer undergoing radical prostatectomy
Quantification of the individual risk of each Gleason pattern, including tertiary Gleason pattern 5, after radical prostatectomy: development of the modified Gleason grade grouping (mGGG) model
Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
Prediction model of gleason score upgrading after radical prostatectomy based on a bayesian network
Increased fatty acid synthase expression in prostate biopsy cores predicts higher Gleason score in radical prostatectomy specimen
Correlation of MRI-lesion targeted biopsy vs. systematic biopsy gleason score with final pathologicalg gleason score after radical prostatectomy
Machine learning prediction of Gleason grade group upgrade between in-bore biopsy and radical prostatectomy pathology
MRI-fusion targeted vs. systematic prostate biopsy - how does the biopsy technique affect Gleason grade concordance and upgrading after radical prostatectomy?
Mri-fusion targeted vs. Systematic prostate biopsy–how does the biopsy technique affect gleason grade concordance and upgrading after radical prostatectomy?
Predicting Gleason sum upgrading from biopsy to radical prostatectomy pathology: a new nomogram and its internal validation
Preoperative prostate health index predicts adverse pathology and Gleason score upgrading after radical prostatectomy for prostate cancer
Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy
Influence of biopsy gleason score on the risk of lymph node invasion in patients with intermediate-risk prostate cancer undergoing radical prostatectomy
Quantification of the individual risk of each Gleason pattern, including tertiary Gleason pattern 5, after radical prostatectomy: development of the modified Gleason grade grouping (mGGG) model
Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
Prediction model of gleason score upgrading after radical prostatectomy based on a bayesian network
Increased fatty acid synthase expression in prostate biopsy cores predicts higher Gleason score in radical prostatectomy specimen
Correlation of MRI-lesion targeted biopsy vs. systematic biopsy gleason score with final pathologicalg gleason score after radical prostatectomy
Machine learning prediction of Gleason grade group upgrade between in-bore biopsy and radical prostatectomy pathology
MRI-fusion targeted vs. systematic prostate biopsy - how does the biopsy technique affect Gleason grade concordance and upgrading after radical prostatectomy?
Mri-fusion targeted vs. Systematic prostate biopsy–how does the biopsy technique affect gleason grade concordance and upgrading after radical prostatectomy?
Predicting Gleason sum upgrading from biopsy to radical prostatectomy pathology: a new nomogram and its internal validation
Preoperative prostate health index predicts adverse pathology and Gleason score upgrading after radical prostatectomy for prostate cancer
Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy
Influence of biopsy gleason score on the risk of lymph node invasion in patients with intermediate-risk prostate cancer undergoing radical prostatectomy
Quantification of the individual risk of each Gleason pattern, including tertiary Gleason pattern 5, after radical prostatectomy: development of the modified Gleason grade grouping (mGGG) model
Favorable intermediate risk prostate cancer with biopsy Gleason score of 6